Welcome to PatchTek

Patchtek’s mission is the development and licensing of a transdermal cannabinoid patch worldwide. Patchtek currently holds multiple patents throughout Europe, the United States, Canada and Australia on a transdermal patch to administer cannibinoids across the skin.

Patchtek is undergoing pre-clinical studies for this device indicated for use of various diseases and for treatment of conditions such as neuropathic pain, nausea, vomiting, anorexia and spasticity.

Patchtek is looking for innovative, quality and sustainable pharmaceutical partners to enhance people’s life by delivering our medical device to patients in need.